Frequency of Tremor Side Effects with Albuterol
Tremor is a common side effect of albuterol, occurring in approximately 20% of patients using the medication. 1
Incidence and Characteristics
Tremor is one of the most frequently reported dose-dependent side effects of albuterol. According to FDA data:
- Tremor occurs in approximately 20% of patients using albuterol sulfate inhalation solution 1
- It is considered a central nervous system side effect 1
- Tremor is typically skeletal muscle tremor 2
Factors Affecting Tremor Incidence
The likelihood and severity of tremor varies based on several factors:
Route of administration: Tremor is more common with:
Dose-dependent relationship: Higher doses lead to increased tremor incidence and severity 4
- A study comparing different doses showed significant dose-related increases in tremor amplitude 4
Duration of therapy: Some tolerance to tremor may develop with continued use
- After 3 weeks of maintenance dosing, tremor responses to rechallenge were diminished 5
Comparison to Other Beta-Agonists
Albuterol tends to cause less tremor than some other beta-agonists:
- In comparative studies, albuterol produced significantly less tremor than terbutaline
- Postural tremor increased by 11.15 units with albuterol versus 32.80 units with terbutaline (p=0.01) 5
Clinical Considerations
For patients concerned about tremor:
- Using the lowest effective dose can minimize tremor 2
- MDIs with spacers result in less systemic absorption and fewer side effects including tremor 2
- Elderly patients and those with pre-existing cardiac conditions may be more sensitive to tremor and other side effects 2
- Tremor is typically most noticeable shortly after administration and diminishes as drug levels decrease
Other Common Side Effects
While tremor is common, other notable side effects include:
- Cardiovascular: tachycardia (1%), hypertension (1%) 1
- Other CNS effects: dizziness (7%), nervousness (4%), headache (3%) 1
- Metabolic: decreased serum potassium levels (hypokalemia) 2
Clinical Pearls
- Tremor is generally benign and self-limiting but can be bothersome to patients
- If tremor is problematic, consider:
- Reducing the dose if clinically appropriate
- Switching to MDI with spacer instead of nebulizer
- Considering alternative bronchodilators like anticholinergics for elderly patients with significant tremor concerns 2
- Patients should be counseled about the possibility of tremor when starting albuterol therapy
Tremor remains one of the most common and recognizable side effects of albuterol therapy but is rarely a reason to discontinue treatment when the medication is otherwise providing effective bronchodilation.